This is unpublished
David Fredricks
Washington Research Foundation logo
September 24, 2025

Washington Research Foundation awards $1M to improve health outcomes

The Washington Research Foundation (WRF) has awarded $1 million to Fred Hutch Cancer Center to continue its support of the organizations’ collaboration to accelerate the development of technologies with significant potential to improve patient health.
Scroll for more
arrow icon
Back to top
Categories
Faculty Research

The Washington Research Foundation (WRF) has awarded $1 million to Fred Hutch Cancer Center to continue its support of the organizations’ collaboration to accelerate the development of technologies with significant potential to improve patient health.

WRF has now provided a total of $3.5 million in grants to the collaboration, which was established in 2021.

Dr. David Fredricks, professor (Allergy and Infectious Diseases) is part of a team who are developing a rapid point-of-care diagnostic for bacterial vaginosis (BV) with the assistance of two earlier awards from the program totaling $300,000. 

BV is a common reason for women to seek medical care for vaginal symptoms, and misdiagnosis can lead to inadequate treatment. BV is associated with increased risks for acquiring sexually transmitted infections, including HIV, and reproductive health and childbirth complications.

The team, who in addition to Fredricks, includes Drs. Sujatha Srinivasan and Dan Raftery, have co-founded a Fred Hutch spinoff company, MetaboliteDx, to help advance diagnostic solutions for infectious causes of vaginitis, including BV.